Avalo Therapeutics, a biotech company, experienced a significant surge in its stock price to a two-year peak on Wednesday following promising outcomes related to its treatment for skin diseases. The company's stock soared amid this positive development, positioning it as a noteworthy competitor against major pharmaceutical companies like AbbVie, Novartis, and Sanofi. This breakthrough news was reported without specifying the information source.